GlaxoSmithKline PLC — Share Issue/Capital Change 2017

May 12, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0510F

GlaxoSmithKline PLC

12 May 2017

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline Share Option Plan - Ordinary Shares
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		3,530,802
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		2,142,9521
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		1,569,653
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		4,104,101
1 This figure includes an adjustment of +142,952 unallotted securities that were allotted under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from the balance for this Scheme.

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline Share Option Plan - ADS
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		9,349,738
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		553,924
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		8,795,814

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		Glaxo Wellcome UK Share Option Scheme
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		5,119,750
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		5,119,750

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		Glaxo Wellcome International Share Option Scheme
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		13,267,156
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		13,267,156

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		Glaxo Wellcome 1999 Share Option Plan
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		1,040,000
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		1,040,000

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		163,606
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		163,606

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		275,420
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		275,420

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		100,000
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		100,000

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline Savings Related Share Option Scheme
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		2,742,626
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		0
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		2,742,626   (the GlaxoSmithKline Savings Related Share Option Scheme has now expired. The balance of 2,742,626 un-allotted shares under this Scheme has therefore lapsed)

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline plc Share Save Plan 2012
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		239,107
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		2,000,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		603,782
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		1,635,325

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
Period of return:	From:	1 November 2016	To:	30 April 2017
Balance of unallotted securities under scheme(s) from previous return:		0
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		600,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		399,9291
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		200,071
1  This figure includes an adjustment of +142,952 allotted securities that were allotted under this Scheme but originally debited from the balance for the block listing under the GlaxoSmithKline Share Option Plan - Ordinary Shares.

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

This information is provided by RNS

The company news service from the London Stock Exchange

END

BLRZMGMKKZZGNZM